# David Ferguson

> David Ferguson is a startup investor at Baxter International. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Baxter International](https://shizune.co/investors/profile/baxter-international)
- Last updated: Aug 2026

David Ferguson is a startup investor at Baxter International.

## About Baxter International

VC Fund · Deerfield, United States

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.The company operates through three segments: BioScience, Medication Delivery, and Renal.- The BioScience segment manufacturesrecombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines.- The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies.- The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic.Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision.The company was founded in 1931 and is headquartered in Deerfield, Illinois.

5 contacts available at Baxter International.

| Name | Title | Profile |
| --- | --- | --- |
| ​Ellen McIntosh | SVP, Associate General Counsel | https://shizune.co/investors/profile/ellen-mcintosh |
| David Ferguson | General Manager, Medication Delivery Global Business Unit | https://shizune.co/investors/profile/david-ferguson-4e16 |
| David Roman | Vice President, Strategy & FP&A | https://shizune.co/investors/profile/david-roman-3 |
| Dennis Crowley | SVP Business Development & Licensing | https://shizune.co/investors/profile/dennis-crowley-c084 |
| Giuseppe Accogli | SVP & President Global Businesses | https://shizune.co/investors/profile/giuseppe-accogli |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co